Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 17 Pancreatic Neoplasms 6 Neoplasm Metastasis 4 Colorectal Neoplasms 3 Breast Neoplasms 3 Biliary Tract Neoplasms 3 Recurrence 2 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Liver Diseases 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Bile Duct Neoplasms 1 Advanced Gastric Cancer 1 Advanced Biliary Tract Cancer 1

Interventions

Cisplatin 131 Cetuximab 80 Radiotherapy 76 Docetaxel 59 Carboplatin 46 pembrolizumab 45 Paclitaxel 44 Fluorouracil 42 Radiotherapy, Intensity-Modulated 35 Drug Therapy 17 Radiation 14 Nivolumab 14 Gefitinib 14 Gemcitabine 13 Surgical Procedures, Operative 12 Oxaliplatin 11 Erlotinib Hydrochloride 11 130-nm albumin-bound paclitaxel 11 Pemetrexed 10 Celecoxib 10 Capecitabine 10 Bevacizumab 10 tislelizumab 9 Filgrastim 9 Amifostine 9 Albumin-Bound Paclitaxel 9 durvalumab 7 atezolizumab 7 Chemoradiotherapy 7 toripalimab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Head and Neck Neoplasms × titanium silicide × Clear all

NCT01645748 2012-07-20

TPSHNSCC

Chonnam National University Hospital

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡